Literature DB >> 2579638

Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.

L C Petersen, J Brender, E Suenson.   

Abstract

The kinetics of plasminogen activation catalysed by urokinase and tissue-type plasminogen activator were investigated. Kinetic measurements are performed by means of a specific chromogenic peptide substrate for plasmin, D-valyl-L-leucyl-L-lysine 4-nitroanilide. Two methods are proposed for the analysis of the resulting progress curve of nitroaniline formation in terms of zymogen-activation kinetics: a graphical transformation of the parabolic curve and transformation of the curve for nitroaniline production into a linear progress curve by the addition of a specific inhibitor of plasmin, bovine pancreatic trypsin inhibitor. The two methods give similar results, suggesting that the reaction between activator and plasminogen is a simple second-order reaction at least at plasminogen concentrations up to about 10 microM. The kinetics of both Glu1-plasminogen (residues 1-790) and Lys77-plasminogen (residues 77-790) activation were investigated. The results confirm previous observations showing that trans-4-(aminomethyl)cyclohexane-1-carboxylic acid at relatively low concentrations enhances the activation rate of Glu1-plasminogen but not that of Lys77-plasminogen. At higher concentrations both Glu1- and Lys77-plasminogen activation are inhibited. The concentration interval for the inhibition of urokinase-catalysed reactions is shown to be very different from that of the tissue-plasminogen activator system. Evidence is presented indicating that binding to the active site of urokinase (KD = 2.0 mM) is responsible for the inhibition of the urokinase system, binding to the active site of tissue-plasminogen activator is approx. 100-fold weaker, and inhibition of the tissue-plasminogen activator system, when monitored by plasmin activity, is mainly due to plasmin inhibition. Poly-D-lysine (Mr 160 000) causes a marked enhancement of plasminogen activation catalysed by tissue-plasminogen activator but not by urokinase. Bell-shaped curves of enhancement as a function of the logarithm of poly-D-lysine concentration are obtained for both Glu1- and Lys77-plasminogen activation, with a maximal effect at about 10 mg/litre. The enhancement of Glu1-plasminogen activation exerted by trans-4-(aminomethyl)cyclohexane-1-carboxylic acid is additive to that of poly-D-lysine, whereas poly-D-lysine-induced enhancement of Lys77-plasminogen activation is abolished by trans-4-(aminomethyl)cyclohexane-1-carboxylic acid. Analogies are drawn up between the effector functions of poly-D-lysine and fibrin on the catalytic activity of tissue-plasminogen activator.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579638      PMCID: PMC1144563          DOI: 10.1042/bj2250149

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Kinetic studies of the urokinase catalysed conversion of NH2-terminal lysine plasminogen to plasmin.

Authors:  U Christensen; S Müllertz
Journal:  Biochim Biophys Acta       Date:  1977-01-11

2.  The hydrolysis of alpha-N-acetylglycyl-l-lysine methyl ester by urokinase.

Authors:  P L Walton
Journal:  Biochim Biophys Acta       Date:  1967-01-11

3.  Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid.

Authors:  S Thorsen; P Kok; T Astrup
Journal:  Thromb Diath Haemorrh       Date:  1974-12-31

4.  Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compounds.

Authors:  S Thorsen; S Müllertz
Journal:  Scand J Clin Lab Invest       Date:  1974-10       Impact factor: 1.713

5.  Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid.

Authors:  H Claeys; J Vermylen
Journal:  Biochim Biophys Acta       Date:  1974-04-11

6.  Measurement of the binding of antifibrinolytic amino acids to various plasminogens.

Authors:  W J Brockway; F J Castellino
Journal:  Arch Biochem Biophys       Date:  1972-07       Impact factor: 4.013

7.  The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation.

Authors:  P J Walther; R L Hill; P A McKee
Journal:  J Biol Chem       Date:  1975-08-10       Impact factor: 5.157

8.  Kinetic mechanism of the activation of human plasminogen by streptokinase.

Authors:  D P Kosow
Journal:  Biochemistry       Date:  1975-10-07       Impact factor: 3.162

9.  Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids.

Authors:  S Thorsen
Journal:  Biochim Biophys Acta       Date:  1975-05-30

10.  Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.

Authors:  E Suenson; O Lützen; S Thorsen
Journal:  Eur J Biochem       Date:  1984-05-02
View more
  6 in total

1.  Positive co-operative binding at two weak lysine-binding sites governs the Glu-plasminogen conformational change.

Authors:  U Christensen; L Mølgaard
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

Review 2.  Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.

Authors:  R Fears
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

3.  Kinetic behaviour of zymogen activation processes in the presence of an inhibitor.

Authors:  R Varón; M C Manjabacas; M García-Moreno; E Valero; F Garcia-Canovas
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

4.  Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159).

Authors:  R Fears; I Dodd; H Ferres; J H Robinson
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

5.  Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator.

Authors:  C Masson; E Angles-Cano
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

6.  A Camelid-derived Antibody Fragment Targeting the Active Site of a Serine Protease Balances between Inhibitor and Substrate Behavior.

Authors:  Tobias Kromann-Hansen; Emil Oldenburg; Kristen Wing Yu Yung; Gholamreza H Ghassabeh; Serge Muyldermans; Paul J Declerck; Mingdong Huang; Peter A Andreasen; Jacky Chi Ki Ngo
Journal:  J Biol Chem       Date:  2016-05-23       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.